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癌转移和复发的机制之一，TFF1 表达失调可以导致肿瘤血管增多，TFF3 与 TFF2
也均能促进肿瘤血管生成。但是，TFF1 在胃癌血管生成调控中的作用与机制尚
有待于进一步研究。 






miRWalk、PICTAR5、ShahAA），筛选并获取 10 条可能调控 TFF1 的 microRNA
信息；其次构建包含有 TFF1 的 3’UTR 序列的荧光素酶报告基因质粒，分别与上
述 microRNA 模拟物共转染胃癌细胞后进行荧光素酶活性检测，结果表明


















组织中的差异表达，并且发现 miR-632 能够通过负向调节 TFF1 表达并促使
MMP9 与 CD34 表达协同上调从而促进了血管生成。 
    综上，本课题不仅明确了 microRNA-632 对 TFF1 表达的负调控作用，而且
探讨了 microRNA-632 通过 TFF1 介导调控胃癌血管生成的分子机制。由此，揭
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Abstract 
Gastric cancer is currently the fifth most common cancer in the world and is the 
third leading cause of cancer-related death. The invasion and distant metastasis of 
cancer cells are the major cause of cancer deaths. Although in recent years with the 
diagnosis of gastric cancer and treatment methods continue to improve, the morbidity 
and mortality has been declined, but the prognosis of stamoch cancer is still not good 
enough, especially in patients with advanced gastric cancer. Tumor angiogenesis is an 
important factor in tumor cell infiltration and distant migrationFurther studies of the 
factors that cause metastasis and invasion of gastric cancer cell can improve accuracy 
of the early diagnosis of gastric cancer and therapeutic effect. 
The trefoil factor (TFF) family is a small molecule polypeptide secreted by the 
gastrointestinal tract of mammals, and they have played various roles in different 
physiological and pathological processes. Trefoil factor 1 (TFF1) is one of the soluble 
proteins secreted by gastric mucus cells. The expression of TFF1 is high in human 
normal gastric mucosa, which can protect the structural integrity of the epidermis and 
maintain its normal function. TFF1 is considered a gastric cancer suppressor gene. 
MicroRNAs are a series of short-chain non-coding RANs, which bind to 3'UTR of the 
corresponding mRNA to inhibit the expression of genes. They play a very important 
role in gene expression regulation by allowing multiple signaling pathways to be 
Influence. Through this way, lots of physiological and pathological processes can be 
adjusted. Previous studies have shown that metastasis and recurrence mechanism of 
gastric cancer may be due to increased number of tumor blood vessels, and trefoil 
factor 1 disorders can lead to increased tumor blood vessels. There are also related 
studies have shown that microRNA regulate the formation of tumor blood vessel. This 
ubject further study the correlation of MicroRNA-632 and trefoil factor 1 (TFF1) 
expression, and to explore the effect of angiogenesis. 
Firstly, We screened through different databases, such as TargetScan, DIANNmT, 
miRanda, miRWalk, PICTAR5, and ShahAA, and find that there are 10 kind of 
microRNA can modulate the expression of TFF1.Secondly, the plasmid of luciferase 
reporter gene containing TFF1 3'UTR was constructed. These miRNAs were 
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activity of LUC in gastric cancer cells was the most significant after transfection with 
miRNA-632, indicating that microRNA-632 could bind to TFF1. Finally, the amount 
of microRNA-632, TFF1 and the density of blood vessels in normal tissues and tumor 
tissues were detected by different experiments. By studying the expression of 
microRNA-632 and TFF1 in different tissues, we found that microRNA-632 could 
promote tumor angiogenesis by negatively regulating TFF1 and affecting 
angiogenesis markers MMP9 and CD34 
Gastric cancer angiogenesis can not only promote the growth of in situ tumors, 
but also can increase the probability of distant metastasis of gastric cancer cells. 
Previous studies have confirmed that the number and density of blood vessels in the 
tumor are positively correlated with the ability of tumor invasion and migration. This 
study further clarified the microRNA-632 and TFF1 on the impact of angiogenesis, 
and establish a molecular mechanism of gastric cancer metastasis affected by 
angiogenesis of gastric cancer. In clinical applications, microRNA-632 and TFF1 can 
be used as a new marker for early diagnosis of gastric cancer and a new target for 
drug therapy. 
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在哺乳动物体内总共检测到有 3 种三叶因子（TFF）：TFF1 也叫作 pS2 或乳




生；TFF2 是一种潜在的抑癌基因；而 TFF3 却是一种致癌基因，肿瘤的生成和
发展与其激活表达量升高有关[27]。 






人源的 TFF1 基因定位于 21q22.3，该基因的构成包含 2 个转录启动子、3 个
外显子和 2 个内含子。TFF1 最早是研究人员在利用雌激素刺激人乳腺癌细胞系
MCF-7 时中获得[30]。成熟的 TFF1 分子量很小，只有大约由 60 个氨基酸残基组
成 6.5kD 大小的多肽。后来的实验证实在正常胃粘膜中有单体、二聚体和复合体
这样的 3 种形式的 TFF1 存在[31]。 
 

















1.2.2 三叶因子 1 在体内的分布情况 
在人体的多种组织中都检测到有 TFF 分布，一般胃肠道的表达量占大部分。
在生理性状态下，胃体和胃窦黏膜上皮细胞可以分泌一种具有保护功能的成分复
杂的黏液，其中的一种成分就是 TFF1，另外也有少量的 TFF1 表达于空肠、回
肠、乳腺、唾液腺、胰腺等处[32, 33]。人的正常胃黏膜中 TFF1 表达量通常较高，
但是也有相关的研究显示，在很多病理条件下 TFF1 表达出现紊乱也可以上调，
例如：炎症、乳腺癌、口腔癌、肺癌、前列腺癌、胰腺癌、结肠癌以及胆管癌[28]。 
1.2.3 三叶因子 1 的主要功能  
三叶因子 1 具有许多生理学功能，其主要的功能是保护胃黏膜，加快上皮
细胞的迁移以促进黏膜的损伤修复[34]。研究证明 TFF1 可以通过调控多种信号分
子来影响细胞的生长、转移及调亡，例如 EGFR、NF-κB 及 β-catenin[35-37]。一些
黏膜病变中 TFF1 表达升高，例如炎症、溃疡，TFF1 在胃肠道粘膜免疫防御过
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